Literature DB >> 2909892

Duchenne muscular dystrophy gene product is not identical in muscle and brain.

U Nudel1, D Zuk, P Einat, E Zeelon, Z Levy, S Neuman, D Yaffe.   

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder resulting in progressive degeneration of the muscle. It affects about 1 in 3,500 male children. Becker's muscular dystrophy is a less severe disease allelic to DMD. Some 30% of DMD patients suffer from various degrees of mental retardation. The giant DMD gene spans about 2,000 kilobases and codes for a 14-kilobase messenger RNA and a protein of molecular weight 427,000. DMD mRNA is most abundant in skeletal and cardiac muscle and less so in smooth muscle. We reported that the expression of the gene is developmentally regulated during the differentiation of primary muscle cultures and in myogenic cell lines in a way similar to the expression of muscle-specific genes such as myosin light chain 2 and skeletal muscle actin. Similar results have been obtained with human primary myogenic cells. Significant levels of DMD mRNA are found in brain tissue. Here we show that the transcript of the DMD gene and the amino terminal of the encoded protein differ in brain and muscle. The 5' ends of these mRNA species are derived from different exons. The results suggest that the two mRNA types are transcribed from different promoters.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909892     DOI: 10.1038/337076a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  57 in total

1.  Lesson of the week: late diagnosis of Duchenne's muscular dystrophy presenting as global developmental delay.

Authors:  C Essex; H Roper
Journal:  BMJ       Date:  2001-07-07

2.  Isolated dystrophin molecules as seen by electron microscopy.

Authors:  F Pons; N Augier; R Heilig; J Léger; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 3.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

4.  A highly informative CACA repeat polymorphism upstream of the human dystrophin gene (DMD).

Authors:  J P Hugnot; D Récan; M Jeanpierre; J C Kaplan; A Tolun
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

5.  Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors.

Authors:  T G Parker; K L Chow; R J Schwartz; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.

Authors:  R D Bies; S F Phelps; M D Cortez; R Roberts; C T Caskey; J S Chamberlain
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 7.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

8.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

10.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.